Renovorx Inc (RNXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RNXT | AZN | AMGN | GILD | BMY |
| Company | Renovorx Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.9200 | 207.27 | 379.29 | 143.55 | 61.18 |
| High | 0.9380 | 209.93 | 390.14 | 150.00 | 62.68 |
| Low | 0.8651 | 206.95 | 378.74 | 143.37 | 61.18 |
| Latest | 0.8830 | 208.45 | 388.16 | 148.95 | 62.37 |
| Change | +0.0180 | +4.47 | +8.83 | +5.18 | +1.27 |
| % Change | +2.08% | +2.19% | +2.33% | +3.60% | +2.08% |
| Volume | 511,300 | 1,996,335 | 3,441,000 | 11,195,500 | 20,741,117 |
| 20-Day Average Volume | 180,290 | 2,562,670 | 3,020,880 | 7,991,295 | 13,974,990 |
| Previous Close | 0.8650 | 203.98 | 379.33 | 143.77 | 61.10 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9528 | 199.14 | 370.17 | 149.28 | 59.84 |
| 20-Day Raw Stochastic | 12.44% | 85.35% | 96.20% | 55.26% | 96.40% |
| 20-Day Relative Strength | 44.07 | 63.41 | 65.63 | 58.54 | 67.42 |
| Weighted Alpha | -37.63 | +47.00 | +36.94 | +40.18 | +19.79 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 80% Sell | 88% Buy | 100% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.26% since 02/20/26 | +2.08% since 02/20/26 | +3.58% since 02/20/26 | -1.62% since 02/20/26 | +2.82% since 02/20/26 |
| Low | 0.8550 on 02/26/26 | 202.64 on 02/26/26 | 374.25 on 02/26/26 | 143.09 on 02/26/26 | 60.64 on 02/23/26 |
| High | 0.9880 on 02/25/26 | 209.93 on 02/27/26 | 390.14 on 02/27/26 | 152.46 on 02/23/26 | 62.67 on 02/27/26 |
| 1-Month | |||||
| %Chg | -1.79% since 01/27/26 | +9.02% since 01/27/26 | +10.49% since 01/27/26 | +5.66% since 01/27/26 | +12.26% since 01/27/26 |
| Low | 0.8550 on 02/26/26 | 183.63 on 02/03/26 | 338.07 on 01/30/26 | 138.23 on 01/29/26 | 54.21 on 01/29/26 |
| High | 1.0800 on 02/02/26 | 212.71 on 02/18/26 | 390.14 on 02/27/26 | 157.29 on 02/11/26 | 62.67 on 02/27/26 |
| 3-Month | |||||
| %Chg | -0.36% since 11/26/25 | +11.69% since 11/26/25 | +12.65% since 11/26/25 | +16.81% since 11/26/25 | +26.64% since 11/26/25 |
| Low | 0.7900 on 12/29/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 48.22 on 12/02/25 |
| High | 1.2500 on 01/09/26 | 212.71 on 02/18/26 | 390.14 on 02/27/26 | 157.29 on 02/11/26 | 62.67 on 02/27/26 |
| 6-Month | |||||
| %Chg | -4.50% since 08/27/25 | +30.40% since 08/27/25 | +34.79% since 08/27/25 | +30.75% since 08/27/25 | +30.95% since 08/27/25 |
| Low | 0.7006 on 11/14/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 1.4500 on 09/19/25 | 212.71 on 02/18/26 | 390.14 on 02/27/26 | 157.29 on 02/11/26 | 62.67 on 02/27/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 31,702 | 316,354,208 | 204,484,656 | 178,479,104 | 124,428,560 |
| Shares Outstanding, K | 36,650 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 40,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -8,810,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 270,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -2,910,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.31 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 11/13/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/30/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.41 | 17.59 | 18.05 | 9.97 |